

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA deamination (GO:0045006) | 7.12634471 |
| 2 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 5.96488226 |
| 3 | cytidine metabolic process (GO:0046087) | 5.80943657 |
| 4 | cytidine catabolic process (GO:0006216) | 5.80943657 |
| 5 | cytidine deamination (GO:0009972) | 5.80943657 |
| 6 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 4.92619025 |
| 7 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 4.91527327 |
| 8 | actin nucleation (GO:0045010) | 4.54434453 |
| 9 | ncRNA 3-end processing (GO:0043628) | 4.37582864 |
| 10 | positive thymic T cell selection (GO:0045059) | 4.30232705 |
| 11 | ribosomal small subunit assembly (GO:0000028) | 4.09172653 |
| 12 | positive T cell selection (GO:0043368) | 3.77471711 |
| 13 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.76898192 |
| 14 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.76165451 |
| 15 | ribosomal small subunit biogenesis (GO:0042274) | 3.65833479 |
| 16 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.58535957 |
| 17 | regulation of regulatory T cell differentiation (GO:0045589) | 3.54875047 |
| 18 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.40812844 |
| 19 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.39785375 |
| 20 | ATP synthesis coupled proton transport (GO:0015986) | 3.39785375 |
| 21 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.33897036 |
| 22 | NADH metabolic process (GO:0006734) | 3.32313407 |
| 23 | response to interferon-beta (GO:0035456) | 3.28083430 |
| 24 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.24133121 |
| 25 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 3.23920566 |
| 26 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.23287636 |
| 27 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 3.23124688 |
| 28 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.14479128 |
| 29 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 3.13631080 |
| 30 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 3.11302399 |
| 31 | water-soluble vitamin biosynthetic process (GO:0042364) | 3.05534934 |
| 32 | immunoglobulin mediated immune response (GO:0016064) | 3.02574066 |
| 33 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.00020401 |
| 34 | respiratory electron transport chain (GO:0022904) | 2.99309340 |
| 35 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.98879938 |
| 36 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.98879938 |
| 37 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.97557307 |
| 38 | T cell migration (GO:0072678) | 2.97104732 |
| 39 | electron transport chain (GO:0022900) | 2.97071770 |
| 40 | negative T cell selection (GO:0043383) | 2.96311676 |
| 41 | mast cell activation involved in immune response (GO:0002279) | 2.92973849 |
| 42 | mast cell degranulation (GO:0043303) | 2.92973849 |
| 43 | regulation of gamma-delta T cell activation (GO:0046643) | 2.92867589 |
| 44 | fucose catabolic process (GO:0019317) | 2.91955389 |
| 45 | L-fucose metabolic process (GO:0042354) | 2.91955389 |
| 46 | L-fucose catabolic process (GO:0042355) | 2.91955389 |
| 47 | T cell receptor signaling pathway (GO:0050852) | 2.91710138 |
| 48 | T cell costimulation (GO:0031295) | 2.91218414 |
| 49 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.89199109 |
| 50 | lymphocyte costimulation (GO:0031294) | 2.88057765 |
| 51 | negative regulation of T cell apoptotic process (GO:0070233) | 2.87739386 |
| 52 | tryptophan metabolic process (GO:0006568) | 2.87653868 |
| 53 | behavioral response to nicotine (GO:0035095) | 2.87631124 |
| 54 | negative regulation of phagocytosis (GO:0050765) | 2.87031201 |
| 55 | tryptophan catabolic process (GO:0006569) | 2.86840166 |
| 56 | indole-containing compound catabolic process (GO:0042436) | 2.86840166 |
| 57 | indolalkylamine catabolic process (GO:0046218) | 2.86840166 |
| 58 | thymic T cell selection (GO:0045061) | 2.86826695 |
| 59 | piRNA metabolic process (GO:0034587) | 2.85408924 |
| 60 | positive regulation of cell killing (GO:0031343) | 2.84101235 |
| 61 | sulfation (GO:0051923) | 2.82382360 |
| 62 | negative regulation of viral genome replication (GO:0045071) | 2.80240522 |
| 63 | regulation of cell killing (GO:0031341) | 2.78074917 |
| 64 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 2.78023307 |
| 65 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 2.78023307 |
| 66 | response to pheromone (GO:0019236) | 2.76793648 |
| 67 | positive regulation of defense response to virus by host (GO:0002230) | 2.75541872 |
| 68 | positive regulation of B cell differentiation (GO:0045579) | 2.72946490 |
| 69 | cellular response to interleukin-15 (GO:0071350) | 2.72304679 |
| 70 | mast cell activation (GO:0045576) | 2.68631431 |
| 71 | protein neddylation (GO:0045116) | 2.66866989 |
| 72 | positive regulation of interleukin-8 secretion (GO:2000484) | 2.65989328 |
| 73 | adaptation of signaling pathway (GO:0023058) | 2.65865598 |
| 74 | positive regulation of calcium-mediated signaling (GO:0050850) | 2.65713169 |
| 75 | protein import into peroxisome matrix (GO:0016558) | 2.64603358 |
| 76 | regulation of activation of Janus kinase activity (GO:0010533) | 2.64315936 |
| 77 | pyrimidine nucleoside catabolic process (GO:0046135) | 2.64297467 |
| 78 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 2.61855914 |
| 79 | sequestering of actin monomers (GO:0042989) | 2.59497039 |
| 80 | indolalkylamine metabolic process (GO:0006586) | 2.59491419 |
| 81 | detection of light stimulus involved in visual perception (GO:0050908) | 2.58948628 |
| 82 | detection of light stimulus involved in sensory perception (GO:0050962) | 2.58948628 |
| 83 | organelle membrane fusion (GO:0090174) | 2.58285068 |
| 84 | negative thymic T cell selection (GO:0045060) | 2.58051270 |
| 85 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.57149399 |
| 86 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.56915669 |
| 87 | cellular response to interferon-beta (GO:0035458) | 2.54642089 |
| 88 | regulation of interleukin-8 secretion (GO:2000482) | 2.54338014 |
| 89 | rRNA modification (GO:0000154) | 2.53906697 |
| 90 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.53152485 |
| 91 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.52107339 |
| 92 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.52010034 |
| 93 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.51756112 |
| 94 | adenosine metabolic process (GO:0046085) | 2.48813211 |
| 95 | positive regulation of chemokine secretion (GO:0090197) | 2.47175307 |
| 96 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 2.46191090 |
| 97 | cytolysis (GO:0019835) | 2.46009881 |
| 98 | purine-containing compound salvage (GO:0043101) | 2.41089382 |
| 99 | autophagic vacuole fusion (GO:0000046) | 2.40955168 |
| 100 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.40727654 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 5.95035001 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.76918634 |
| 3 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.67623149 |
| 4 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 3.20472015 |
| 5 | VDR_22108803_ChIP-Seq_LS180_Human | 3.02075189 |
| 6 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.82724882 |
| 7 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.82469842 |
| 8 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.76297264 |
| 9 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.68425877 |
| 10 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.66500638 |
| 11 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.53149728 |
| 12 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.39077052 |
| 13 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.23580472 |
| 14 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.16993807 |
| 15 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.04554988 |
| 16 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.02369935 |
| 17 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.99390147 |
| 18 | MYB_26560356_Chip-Seq_TH2_Human | 1.97739168 |
| 19 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.76916163 |
| 20 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.75551366 |
| 21 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.72214602 |
| 22 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.65037938 |
| 23 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.58901073 |
| 24 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.58058038 |
| 25 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.56239350 |
| 26 | GATA3_26560356_Chip-Seq_TH2_Human | 1.55488344 |
| 27 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.54600465 |
| 28 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.54325479 |
| 29 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.54325479 |
| 30 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.52084059 |
| 31 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.51105248 |
| 32 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.45920914 |
| 33 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.45459057 |
| 34 | AR_20517297_ChIP-Seq_VCAP_Human | 1.44792816 |
| 35 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.44761909 |
| 36 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.44757295 |
| 37 | NCOR_22424771_ChIP-Seq_293T_Human | 1.42784248 |
| 38 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.42485746 |
| 39 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.41318748 |
| 40 | TAF2_19829295_ChIP-Seq_ESCs_Human | 1.40907517 |
| 41 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.40725399 |
| 42 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.40666275 |
| 43 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.36506206 |
| 44 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 1.34721042 |
| 45 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 1.34075820 |
| 46 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.32647694 |
| 47 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.30415008 |
| 48 | ERA_21632823_ChIP-Seq_H3396_Human | 1.28941928 |
| 49 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.28177435 |
| 50 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.27654747 |
| 51 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.27245025 |
| 52 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.27236627 |
| 53 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.26229655 |
| 54 | ERG_20517297_ChIP-Seq_VCAP_Human | 1.25559016 |
| 55 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.23388460 |
| 56 | MYC_19829295_ChIP-Seq_ESCs_Human | 1.21040496 |
| 57 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.20852715 |
| 58 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.18823716 |
| 59 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.18823716 |
| 60 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.18038072 |
| 61 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 1.15682838 |
| 62 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 1.14723664 |
| 63 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.14189947 |
| 64 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.13722874 |
| 65 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.12951617 |
| 66 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.12676243 |
| 67 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.12676243 |
| 68 | FUS_26573619_Chip-Seq_HEK293_Human | 1.10264986 |
| 69 | P300_27268052_Chip-Seq_Bcells_Human | 1.09745480 |
| 70 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.09456429 |
| 71 | EWS_26573619_Chip-Seq_HEK293_Human | 1.08184167 |
| 72 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.06257809 |
| 73 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.06206106 |
| 74 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.05523879 |
| 75 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.05073901 |
| 76 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.04423015 |
| 77 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.04402156 |
| 78 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 1.03850723 |
| 79 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.02289591 |
| 80 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.01607813 |
| 81 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 1.01174226 |
| 82 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.00765896 |
| 83 | MYB_26560356_Chip-Seq_TH1_Human | 1.00409240 |
| 84 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.99216186 |
| 85 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.99059449 |
| 86 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.98656975 |
| 87 | SPI1_23547873_ChIP-Seq_NB4_Human | 0.97890014 |
| 88 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.97784670 |
| 89 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.97702576 |
| 90 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.97601118 |
| 91 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.97459783 |
| 92 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.96157681 |
| 93 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.96000681 |
| 94 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.95622566 |
| 95 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.95476685 |
| 96 | HOXB7_26014856_ChIP-Seq_BT474_Human | 0.94936423 |
| 97 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.93597228 |
| 98 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.93429716 |
| 99 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.92119551 |
| 100 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.92087046 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005671_abnormal_response_to | 4.86610362 |
| 2 | MP0001873_stomach_inflammation | 2.90287437 |
| 3 | MP0009785_altered_susceptibility_to | 2.89174126 |
| 4 | MP0006082_CNS_inflammation | 2.72378349 |
| 5 | MP0001835_abnormal_antigen_presentation | 2.70673942 |
| 6 | MP0005645_abnormal_hypothalamus_physiol | 2.32916398 |
| 7 | MP0003763_abnormal_thymus_physiology | 2.25744143 |
| 8 | MP0001800_abnormal_humoral_immune | 2.24143759 |
| 9 | MP0008875_abnormal_xenobiotic_pharmacok | 2.16503905 |
| 10 | MP0004510_myositis | 2.08372041 |
| 11 | MP0005410_abnormal_fertilization | 2.03930063 |
| 12 | MP0003646_muscle_fatigue | 2.02516808 |
| 13 | MP0005000_abnormal_immune_tolerance | 1.99698262 |
| 14 | MP0002166_altered_tumor_susceptibility | 1.92147626 |
| 15 | MP0002138_abnormal_hepatobiliary_system | 1.89316214 |
| 16 | MP0002420_abnormal_adaptive_immunity | 1.88975346 |
| 17 | MP0002723_abnormal_immune_serum | 1.87015550 |
| 18 | MP0001819_abnormal_immune_cell | 1.84789814 |
| 19 | MP0002148_abnormal_hypersensitivity_rea | 1.83940443 |
| 20 | MP0005025_abnormal_response_to | 1.80541522 |
| 21 | MP0003195_calcinosis | 1.80379123 |
| 22 | MP0010155_abnormal_intestine_physiology | 1.79305299 |
| 23 | MP0008872_abnormal_physiological_respon | 1.78165513 |
| 24 | MP0005075_abnormal_melanosome_morpholog | 1.75933047 |
| 25 | MP0009379_abnormal_foot_pigmentation | 1.75584702 |
| 26 | MP0009333_abnormal_splenocyte_physiolog | 1.75047425 |
| 27 | MP0002933_joint_inflammation | 1.74204549 |
| 28 | MP0002452_abnormal_antigen_presenting | 1.73860189 |
| 29 | MP0008877_abnormal_DNA_methylation | 1.72614050 |
| 30 | MP0003879_abnormal_hair_cell | 1.66150385 |
| 31 | MP0005377_hearing/vestibular/ear_phenot | 1.61210375 |
| 32 | MP0003878_abnormal_ear_physiology | 1.61210375 |
| 33 | MP0005646_abnormal_pituitary_gland | 1.58649847 |
| 34 | MP0005551_abnormal_eye_electrophysiolog | 1.55134643 |
| 35 | MP0000372_irregular_coat_pigmentation | 1.53588562 |
| 36 | MP0002006_tumorigenesis | 1.47536008 |
| 37 | MP0005360_urolithiasis | 1.45998931 |
| 38 | MP0003866_abnormal_defecation | 1.45857611 |
| 39 | MP0001845_abnormal_inflammatory_respons | 1.44282964 |
| 40 | MP0000716_abnormal_immune_system | 1.44259437 |
| 41 | MP0001905_abnormal_dopamine_level | 1.43339781 |
| 42 | MP0002419_abnormal_innate_immunity | 1.40157925 |
| 43 | MP0001986_abnormal_taste_sensitivity | 1.39598221 |
| 44 | MP0003724_increased_susceptibility_to | 1.38962859 |
| 45 | MP0006072_abnormal_retinal_apoptosis | 1.38918771 |
| 46 | MP0001968_abnormal_touch/_nociception | 1.37774830 |
| 47 | MP0005389_reproductive_system_phenotype | 1.37134673 |
| 48 | MP0001790_abnormal_immune_system | 1.36322039 |
| 49 | MP0005387_immune_system_phenotype | 1.36322039 |
| 50 | MP0009764_decreased_sensitivity_to | 1.35076334 |
| 51 | MP0002405_respiratory_system_inflammati | 1.33284589 |
| 52 | MP0002398_abnormal_bone_marrow | 1.32289501 |
| 53 | MP0004145_abnormal_muscle_electrophysio | 1.31549325 |
| 54 | MP0000689_abnormal_spleen_morphology | 1.28548091 |
| 55 | MP0001919_abnormal_reproductive_system | 1.28331519 |
| 56 | MP0003011_delayed_dark_adaptation | 1.25185902 |
| 57 | MP0008995_early_reproductive_senescence | 1.21623614 |
| 58 | MP0000685_abnormal_immune_system | 1.19182795 |
| 59 | MP0002722_abnormal_immune_system | 1.17856870 |
| 60 | MP0004147_increased_porphyrin_level | 1.17838275 |
| 61 | MP0002102_abnormal_ear_morphology | 1.17815849 |
| 62 | MP0002837_dystrophic_cardiac_calcinosis | 1.17527998 |
| 63 | MP0000703_abnormal_thymus_morphology | 1.14447147 |
| 64 | MP0001765_abnormal_ion_homeostasis | 1.13115708 |
| 65 | MP0002876_abnormal_thyroid_physiology | 1.10157564 |
| 66 | MP0002429_abnormal_blood_cell | 1.09350011 |
| 67 | MP0008469_abnormal_protein_level | 1.06020716 |
| 68 | MP0004947_skin_inflammation | 1.04961057 |
| 69 | MP0003436_decreased_susceptibility_to | 1.01939455 |
| 70 | MP0004885_abnormal_endolymph | 0.99617160 |
| 71 | MP0002160_abnormal_reproductive_system | 0.98371021 |
| 72 | MP0005084_abnormal_gallbladder_morpholo | 0.98126192 |
| 73 | MP0001663_abnormal_digestive_system | 0.97824457 |
| 74 | MP0005636_abnormal_mineral_homeostasis | 0.96316160 |
| 75 | MP0002736_abnormal_nociception_after | 0.95201022 |
| 76 | MP0003252_abnormal_bile_duct | 0.93852164 |
| 77 | MP0001984_abnormal_olfaction | 0.93235088 |
| 78 | MP0005253_abnormal_eye_physiology | 0.91621539 |
| 79 | MP0005174_abnormal_tail_pigmentation | 0.87731766 |
| 80 | MP0003806_abnormal_nucleotide_metabolis | 0.86272671 |
| 81 | MP0001533_abnormal_skeleton_physiology | 0.85908100 |
| 82 | MP0001485_abnormal_pinna_reflex | 0.84887875 |
| 83 | MP0000013_abnormal_adipose_tissue | 0.84525725 |
| 84 | MP0002638_abnormal_pupillary_reflex | 0.83631326 |
| 85 | MP0001727_abnormal_embryo_implantation | 0.82899573 |
| 86 | MP0005085_abnormal_gallbladder_physiolo | 0.81898038 |
| 87 | MP0009643_abnormal_urine_homeostasis | 0.81414158 |
| 88 | MP0006276_abnormal_autonomic_nervous | 0.79532048 |
| 89 | MP0002277_abnormal_respiratory_mucosa | 0.77877162 |
| 90 | MP0009763_increased_sensitivity_to | 0.75880118 |
| 91 | MP0002693_abnormal_pancreas_physiology | 0.74466200 |
| 92 | MP0000230_abnormal_systemic_arterial | 0.73490936 |
| 93 | MP0001929_abnormal_gametogenesis | 0.72292939 |
| 94 | MP0002272_abnormal_nervous_system | 0.71695009 |
| 95 | MP0002095_abnormal_skin_pigmentation | 0.71664318 |
| 96 | MP0003786_premature_aging | 0.70669534 |
| 97 | MP0003183_abnormal_peptide_metabolism | 0.70079544 |
| 98 | MP0005167_abnormal_blood-brain_barrier | 0.69741725 |
| 99 | MP0005166_decreased_susceptibility_to | 0.69397015 |
| 100 | MP0003718_maternal_effect | 0.69343500 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Attenuation of retinal blood vessels (HP:0007843) | 4.70463482 |
| 2 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.57506527 |
| 3 | Constricted visual fields (HP:0001133) | 4.03859360 |
| 4 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 3.98743347 |
| 5 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 3.91232796 |
| 6 | IgG deficiency (HP:0004315) | 3.85318687 |
| 7 | T lymphocytopenia (HP:0005403) | 3.70532444 |
| 8 | Decreased central vision (HP:0007663) | 3.57450055 |
| 9 | Severe combined immunodeficiency (HP:0004430) | 3.52756705 |
| 10 | Abnormality of T cell number (HP:0011839) | 3.41839725 |
| 11 | Abnormality of macular pigmentation (HP:0008002) | 3.39452912 |
| 12 | Striae distensae (HP:0001065) | 3.24293905 |
| 13 | Cone-rod dystrophy (HP:0000548) | 3.18595764 |
| 14 | Abnormality of B cell number (HP:0010975) | 3.18089059 |
| 15 | Thyroiditis (HP:0100646) | 3.03266533 |
| 16 | Abnormal rod and cone electroretinograms (HP:0008323) | 3.01420977 |
| 17 | Mitochondrial inheritance (HP:0001427) | 2.97147555 |
| 18 | Abolished electroretinogram (ERG) (HP:0000550) | 2.93910964 |
| 19 | B lymphocytopenia (HP:0010976) | 2.85148108 |
| 20 | Hepatocellular necrosis (HP:0001404) | 2.82197757 |
| 21 | Acute necrotizing encephalopathy (HP:0006965) | 2.76939714 |
| 22 | Abnormality of T cells (HP:0002843) | 2.72163367 |
| 23 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.71004793 |
| 24 | Optic disc pallor (HP:0000543) | 2.70542048 |
| 25 | Combined immunodeficiency (HP:0005387) | 2.68621343 |
| 26 | Congenital stationary night blindness (HP:0007642) | 2.67883116 |
| 27 | Abnormality of the prostate (HP:0008775) | 2.66019739 |
| 28 | Pendular nystagmus (HP:0012043) | 2.65689315 |
| 29 | Autoimmune hemolytic anemia (HP:0001890) | 2.65631280 |
| 30 | Hepatic necrosis (HP:0002605) | 2.62490294 |
| 31 | Round ear (HP:0100830) | 2.62112001 |
| 32 | Chronic diarrhea (HP:0002028) | 2.61093760 |
| 33 | IgM deficiency (HP:0002850) | 2.59627435 |
| 34 | Hypoproteinemia (HP:0003075) | 2.58064942 |
| 35 | Aplastic anemia (HP:0001915) | 2.57390542 |
| 36 | Increased CSF lactate (HP:0002490) | 2.51874070 |
| 37 | Progressive macrocephaly (HP:0004481) | 2.44750453 |
| 38 | Absent/shortened dynein arms (HP:0200106) | 2.44245544 |
| 39 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.44245544 |
| 40 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 2.39812842 |
| 41 | Increased intramyocellular lipid droplets (HP:0012240) | 2.39141348 |
| 42 | Abnormal albumin level (HP:0012116) | 2.35189970 |
| 43 | Hypoalbuminemia (HP:0003073) | 2.35189970 |
| 44 | Type 2 muscle fiber atrophy (HP:0003554) | 2.33541341 |
| 45 | Acute encephalopathy (HP:0006846) | 2.33124040 |
| 46 | Asplenia (HP:0001746) | 2.31986470 |
| 47 | Abnormality of eosinophils (HP:0001879) | 2.30738401 |
| 48 | Increased hepatocellular lipid droplets (HP:0006565) | 2.30154022 |
| 49 | Keratoconus (HP:0000563) | 2.29708162 |
| 50 | Increased corneal curvature (HP:0100692) | 2.29708162 |
| 51 | Renal Fanconi syndrome (HP:0001994) | 2.27332435 |
| 52 | Cerebral edema (HP:0002181) | 2.21602584 |
| 53 | Recurrent bronchitis (HP:0002837) | 2.20194795 |
| 54 | Pancreatic fibrosis (HP:0100732) | 2.16922573 |
| 55 | Toxemia of pregnancy (HP:0100603) | 2.15799324 |
| 56 | Encephalitis (HP:0002383) | 2.13711013 |
| 57 | Panhypogammaglobulinemia (HP:0003139) | 2.12743006 |
| 58 | Hypoplasia of the uterus (HP:0000013) | 2.11795612 |
| 59 | Myositis (HP:0100614) | 2.09915822 |
| 60 | Lipid accumulation in hepatocytes (HP:0006561) | 2.08458196 |
| 61 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.06100116 |
| 62 | Cupped ribs (HP:0000887) | 2.05508686 |
| 63 | Stomatitis (HP:0010280) | 2.03750054 |
| 64 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 2.03586159 |
| 65 | Pancreatic cysts (HP:0001737) | 2.01321543 |
| 66 | Volvulus (HP:0002580) | 1.99495602 |
| 67 | Muscle fiber atrophy (HP:0100295) | 1.98261610 |
| 68 | Congenital, generalized hypertrichosis (HP:0004540) | 1.97698864 |
| 69 | Abnormal drinking behavior (HP:0030082) | 1.97429162 |
| 70 | Polydipsia (HP:0001959) | 1.97429162 |
| 71 | Recurrent sinusitis (HP:0011108) | 1.97362359 |
| 72 | Increased muscle lipid content (HP:0009058) | 1.96996262 |
| 73 | Abnormality of T cell physiology (HP:0011840) | 1.95941752 |
| 74 | Optic neuritis (HP:0100653) | 1.95791481 |
| 75 | Retrobulbar optic neuritis (HP:0100654) | 1.95791481 |
| 76 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.93724637 |
| 77 | Abnormality of urine glucose concentration (HP:0011016) | 1.93381451 |
| 78 | Glycosuria (HP:0003076) | 1.93381451 |
| 79 | Ketosis (HP:0001946) | 1.93042127 |
| 80 | Recurrent otitis media (HP:0000403) | 1.89601252 |
| 81 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.89510872 |
| 82 | Recurrent cutaneous fungal infections (HP:0011370) | 1.89510872 |
| 83 | Vasculitis (HP:0002633) | 1.89079432 |
| 84 | Agammaglobulinemia (HP:0004432) | 1.87184164 |
| 85 | Cerebral palsy (HP:0100021) | 1.86628476 |
| 86 | Leukocytosis (HP:0001974) | 1.86469349 |
| 87 | Hypothermia (HP:0002045) | 1.85468556 |
| 88 | Alkalosis (HP:0001948) | 1.84978732 |
| 89 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.84297688 |
| 90 | Type I transferrin isoform profile (HP:0003642) | 1.82382451 |
| 91 | True hermaphroditism (HP:0010459) | 1.81873672 |
| 92 | Hyperglycinemia (HP:0002154) | 1.81754353 |
| 93 | Lethargy (HP:0001254) | 1.80313896 |
| 94 | Hemiplegia (HP:0002301) | 1.80173083 |
| 95 | Emotional lability (HP:0000712) | 1.79484829 |
| 96 | Lactic acidosis (HP:0003128) | 1.78651112 |
| 97 | Exertional dyspnea (HP:0002875) | 1.78443892 |
| 98 | Eosinophilia (HP:0001880) | 1.78370078 |
| 99 | Bronchitis (HP:0012387) | 1.77097826 |
| 100 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 1.75983709 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TESK2 | 3.96362877 |
| 2 | KIT | 3.95939331 |
| 3 | KDR | 3.57928886 |
| 4 | TXK | 3.55886359 |
| 5 | TLK1 | 3.52613240 |
| 6 | BCKDK | 3.34564272 |
| 7 | TAOK3 | 2.85930434 |
| 8 | ZAK | 2.67969489 |
| 9 | FES | 2.55028768 |
| 10 | FRK | 2.53076189 |
| 11 | TEC | 2.48283372 |
| 12 | MAP4K1 | 2.47188168 |
| 13 | MAP4K2 | 2.30011556 |
| 14 | SCYL2 | 2.12995261 |
| 15 | TIE1 | 2.08891613 |
| 16 | ADRBK2 | 2.05970134 |
| 17 | SYK | 1.78133492 |
| 18 | ITK | 1.73817522 |
| 19 | GRK1 | 1.65100460 |
| 20 | STK16 | 1.64946802 |
| 21 | VRK2 | 1.61375004 |
| 22 | GRK6 | 1.59268382 |
| 23 | IKBKE | 1.48942005 |
| 24 | VRK1 | 1.41583886 |
| 25 | INSRR | 1.39359433 |
| 26 | IKBKB | 1.37257293 |
| 27 | TESK1 | 1.35450019 |
| 28 | PLK4 | 1.30961194 |
| 29 | NUAK1 | 1.25972984 |
| 30 | CSF1R | 1.25117114 |
| 31 | BTK | 1.22237268 |
| 32 | MST4 | 1.22151588 |
| 33 | WNK4 | 1.20376460 |
| 34 | EIF2AK3 | 1.17824938 |
| 35 | CSK | 1.16966006 |
| 36 | BMPR1B | 1.13379949 |
| 37 | LIMK1 | 1.10330818 |
| 38 | LCK | 1.07775586 |
| 39 | PRKCQ | 1.07440449 |
| 40 | TNK2 | 1.06993019 |
| 41 | TBK1 | 0.99306928 |
| 42 | LYN | 0.92943419 |
| 43 | ACVR1B | 0.89629766 |
| 44 | PLK2 | 0.83197610 |
| 45 | PIK3CG | 0.82602405 |
| 46 | RPS6KA5 | 0.79534252 |
| 47 | PHKG2 | 0.74207667 |
| 48 | PHKG1 | 0.74207667 |
| 49 | ZAP70 | 0.74006056 |
| 50 | ADRBK1 | 0.73717302 |
| 51 | STK39 | 0.72453803 |
| 52 | PASK | 0.69272611 |
| 53 | WNK3 | 0.67621387 |
| 54 | PINK1 | 0.63999970 |
| 55 | TYRO3 | 0.60773312 |
| 56 | NME2 | 0.57487263 |
| 57 | JAK3 | 0.56280957 |
| 58 | MAPKAPK5 | 0.56205595 |
| 59 | OBSCN | 0.53623918 |
| 60 | OXSR1 | 0.53317401 |
| 61 | GRK7 | 0.52710480 |
| 62 | PRKCA | 0.50081059 |
| 63 | MYLK | 0.46181233 |
| 64 | DAPK1 | 0.45906409 |
| 65 | CSNK1G3 | 0.44380663 |
| 66 | INSR | 0.44230735 |
| 67 | PRKACA | 0.42141220 |
| 68 | PIM2 | 0.42091751 |
| 69 | EGFR | 0.41937653 |
| 70 | IGF1R | 0.40709191 |
| 71 | FYN | 0.39899945 |
| 72 | CDK19 | 0.38356920 |
| 73 | ERBB3 | 0.38235556 |
| 74 | PRKCG | 0.37346014 |
| 75 | BMPR2 | 0.37261000 |
| 76 | GRK5 | 0.36047538 |
| 77 | PRKCI | 0.35614264 |
| 78 | RIPK4 | 0.34868225 |
| 79 | ABL1 | 0.34593859 |
| 80 | HCK | 0.33845960 |
| 81 | SRC | 0.33384654 |
| 82 | MAPK11 | 0.32913351 |
| 83 | MUSK | 0.32023907 |
| 84 | ABL2 | 0.31849198 |
| 85 | MATK | 0.31777890 |
| 86 | MAPKAPK3 | 0.31749710 |
| 87 | ARAF | 0.31417058 |
| 88 | CSNK1G1 | 0.31046610 |
| 89 | FLT3 | 0.30182234 |
| 90 | PRKCB | 0.28716215 |
| 91 | PIM1 | 0.27515437 |
| 92 | MAP2K6 | 0.27262732 |
| 93 | FGFR2 | 0.26491925 |
| 94 | MAPK13 | 0.26389793 |
| 95 | MAP3K14 | 0.26008589 |
| 96 | MAP3K12 | 0.25322030 |
| 97 | MKNK1 | 0.25240992 |
| 98 | CSNK1A1 | 0.24430881 |
| 99 | PRKCD | 0.23825380 |
| 100 | CSNK2A1 | 0.23439741 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 4.25730229 |
| 2 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.32702938 |
| 3 | Proteasome_Homo sapiens_hsa03050 | 3.29986008 |
| 4 | Allograft rejection_Homo sapiens_hsa05330 | 3.16806991 |
| 5 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 3.12675252 |
| 6 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 3.06087953 |
| 7 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.83871051 |
| 8 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.67775440 |
| 9 | Asthma_Homo sapiens_hsa05310 | 2.65080269 |
| 10 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.62913744 |
| 11 | Ribosome_Homo sapiens_hsa03010 | 2.42462780 |
| 12 | Parkinsons disease_Homo sapiens_hsa05012 | 2.33323396 |
| 13 | Phototransduction_Homo sapiens_hsa04744 | 2.29727240 |
| 14 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.94854850 |
| 15 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.85166186 |
| 16 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.78019639 |
| 17 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.74196541 |
| 18 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.66135855 |
| 19 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.56852528 |
| 20 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.49083496 |
| 21 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.46951147 |
| 22 | Alzheimers disease_Homo sapiens_hsa05010 | 1.46448525 |
| 23 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.45404152 |
| 24 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.43560518 |
| 25 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.36829239 |
| 26 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.34501454 |
| 27 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.34368593 |
| 28 | Huntingtons disease_Homo sapiens_hsa05016 | 1.31699171 |
| 29 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.24246632 |
| 30 | Viral myocarditis_Homo sapiens_hsa05416 | 1.23005495 |
| 31 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.19420142 |
| 32 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.17995703 |
| 33 | RNA polymerase_Homo sapiens_hsa03020 | 1.17907962 |
| 34 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.12875592 |
| 35 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.12198795 |
| 36 | Peroxisome_Homo sapiens_hsa04146 | 1.10911331 |
| 37 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.07097973 |
| 38 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.01877180 |
| 39 | Olfactory transduction_Homo sapiens_hsa04740 | 0.99659796 |
| 40 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.96886543 |
| 41 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.95647804 |
| 42 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.94998813 |
| 43 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.93330731 |
| 44 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.92715868 |
| 45 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.91929297 |
| 46 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.90390861 |
| 47 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.86334020 |
| 48 | Retinol metabolism_Homo sapiens_hsa00830 | 0.83088702 |
| 49 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.81526551 |
| 50 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.81405656 |
| 51 | RNA degradation_Homo sapiens_hsa03018 | 0.79707160 |
| 52 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.78708235 |
| 53 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.78489830 |
| 54 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.78188486 |
| 55 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.77762466 |
| 56 | Purine metabolism_Homo sapiens_hsa00230 | 0.74750208 |
| 57 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.72620819 |
| 58 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.70837609 |
| 59 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.68023475 |
| 60 | Protein export_Homo sapiens_hsa03060 | 0.67663041 |
| 61 | Malaria_Homo sapiens_hsa05144 | 0.64699328 |
| 62 | Leishmaniasis_Homo sapiens_hsa05140 | 0.63831755 |
| 63 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.63213051 |
| 64 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.62553430 |
| 65 | Measles_Homo sapiens_hsa05162 | 0.61691995 |
| 66 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.60189911 |
| 67 | Histidine metabolism_Homo sapiens_hsa00340 | 0.59216824 |
| 68 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.58772471 |
| 69 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.57502509 |
| 70 | Homologous recombination_Homo sapiens_hsa03440 | 0.57273526 |
| 71 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.56704645 |
| 72 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.54219020 |
| 73 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.52600946 |
| 74 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.50783707 |
| 75 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.48030895 |
| 76 | ABC transporters_Homo sapiens_hsa02010 | 0.47978877 |
| 77 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.47403485 |
| 78 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.47212917 |
| 79 | Metabolic pathways_Homo sapiens_hsa01100 | 0.46295021 |
| 80 | Taste transduction_Homo sapiens_hsa04742 | 0.46061045 |
| 81 | Shigellosis_Homo sapiens_hsa05131 | 0.44779383 |
| 82 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.44582492 |
| 83 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.41152730 |
| 84 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.40569737 |
| 85 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.39388981 |
| 86 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.39115056 |
| 87 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.37260548 |
| 88 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.36659356 |
| 89 | Nicotine addiction_Homo sapiens_hsa05033 | 0.35468247 |
| 90 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.34692627 |
| 91 | Base excision repair_Homo sapiens_hsa03410 | 0.32151276 |
| 92 | Salivary secretion_Homo sapiens_hsa04970 | 0.30774380 |
| 93 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.28101599 |
| 94 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.24902802 |
| 95 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.23044810 |
| 96 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.21882124 |
| 97 | Sulfur relay system_Homo sapiens_hsa04122 | 0.20607711 |
| 98 | Pertussis_Homo sapiens_hsa05133 | 0.19615605 |
| 99 | Basal transcription factors_Homo sapiens_hsa03022 | 0.19219405 |
| 100 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.18387143 |

